RBF Capital’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-49,122
| Closed | -$287K | – | 543 |
|
|
2022
Q4 | $287K | Sell |
49,122
-15,781
| -24% | -$92.2K | 0.02% | 408 |
|
|
2022
Q3 | $435K | Sell |
64,903
-6,198
| -9% | -$41.5K | 0.04% | 343 |
|
|
2022
Q2 | $294K | Hold |
71,101
| – | – | 0.02% | 416 |
|
|
2022
Q1 | $262K | Sell |
71,101
-3,522
| -5% | -$13K | 0.02% | 435 |
|
|
2021
Q4 | $235K | Sell |
74,623
-62,883
| -46% | -$198K | 0.01% | 453 |
|
|
2021
Q3 | $450K | Sell |
137,506
-1,600
| -1% | -$5.24K | 0.03% | 354 |
|
|
2021
Q2 | $587K | Buy |
+139,106
| New | +$587K | 0.03% | 342 |
|